# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-23-008843
Filing Date
2023-03-31
Accepted
2023-03-31 16:11:40
Documents
117
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | nby20221231_10k.htm iXBRL | 10-K | 2249116
2 | EXHIBIT 4.1 | ex_485491.htm | EX-4.1 | 16060
3 | EXHIBIT 10.15 | ex_485490.htm | EX-10.15 | 19505
4 | EXHIBIT 10.33 | ex_486069.htm | EX-10.33 | 61384
5 | EXHIBIT 21 | ex_485489.htm | EX-21 | 2384
6 | EXHIBIT 23.1 | ex_485488.htm | EX-23.1 | 2664
7 | EXHIBIT 31.1 | ex_485487.htm | EX-31.1 | 8263
8 | EXHIBIT 31.2 | ex_485486.htm | EX-31.2 | 8446
9 | EXHIBIT 32.1 | ex_485485.htm | EX-32.1 | 4015
10 | EXHIBIT 32.2 | ex_485484.htm | EX-32.2 | 4012
16 |  | img002.jpg | GRAPHIC | 5009
| Complete submission text file | 0001437749-23-008843.txt |  | 12458303

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA | nby-20221231.xsd | EX-101.SCH | 120297
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nby-20221231_cal.xml | EX-101.CAL | 83351
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nby-20221231_def.xml | EX-101.DEF | 767931
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nby-20221231_lab.xml | EX-101.LAB | 622680
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nby-20221231_pre.xml | EX-101.PRE | 813113
111 | EXTRACTED XBRL INSTANCE DOCUMENT | nby20221231_10k_htm.xml | XML | 2203069

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 23787748
SIC: 2834 Pharmaceutical Preparations